Beam Therapeutics (BEAM) Sof foyda bo'yicha sotuv rentabelligi

Beam Therapeutics Corp (BEAM) grafik logotipi

Beam Therapeutics Inc. (BEAM) aniq baza tahrirlashni tijoratlashtirishga e'tibor qaratadi va sog'liqni saqlash gigantlari bilan ittifoqlar orqali kapital jalb qilmoqda. GURU.Markets grafik ma'lumotlaridagi sof foyda marjasi samaradorlikni aniq ko'rsatadi, bunda -73.00 darajasi eng so'nggi qiymatlarni aks ettiradi. Kompaniya jigar va qon patologiyalari uchun terapiyalarni ishlab chiqish orqali risklarni kamaytirmoqda, xavfsiz nuqtali genom tahrirlashdagi yetakchiligi va patent portfeli esa kuchli himoya to'sig'ini ta'minlaydi.

BEAM: Beam Tx Kompaniyaning sof rentabelligi 04.07.2022 - 20.11.2026

Beam Tx (BEAM) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiya kursi va ekspertlarning narx prognozi:
- bozor kapitallashuvi tafsilotlari:
Kompaniyaning barcha koʻrsatkichlari tahlili:Beam Therapeutics, BEAM
Beam Therapeutics Corp yetakchi tovari

Investorlar Beam Therapeutics Inc. (BEAM) salohiyatini biznesning daromadlarni sof foydaga aylantirish qobiliyati orqali bahlamoqda, bu esa yakuniy foydaning umumiy savdoga nisbati bilan o'lchanadi. Savdo marjasi tendentsiyasini tahlil qilish erta bosqichdagi klinik sinovlarning ulkan xarajatlari va genlarni tahrirlash xavfsizligi bilan bog'liq risklar joriy daromadlilikni qanday tarzda pasaytirayotganini ko'rsatadi, bu esa kompaniyaning tijorat nuqtai nazaridan zararsizlanishini uzoq muddatli gipotezaga aylantirmoqda.

Beam Therapeutics Inc. kimlar bilan raqobatlashadi

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|SRPT: Sof foyda bo'yicha sotuv rentabelligi|Sof marja Twist Bioscience|TXG (10x Genomics) - Sof foyda bo'yicha sotuv rentabelligi|Intellia Therapeutics, Inc. (NTLA) - Sotuvning sof marjinal rentabelligi|Sof marja Stoke Therapeutics Inc|BLFS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi WVE (Wave Life Sciences Corp)|Kompaniya sotuv marjasi Maze Therapeutics Corp|Sionna Therapeutics Inc - Sof foyda bo'yicha sotuv rentabelligi|PRME (primemedicine.com) - Sof foyda marjasi|TSHA - Sof marja|QURE (uniQure) - Sotuvning sof rentabelligi|MeiraGTx Corp (MGTX) - Sof marja|Regenxbio - Sof foyda normasi|Sof marja solidbio.com|Sof marja ocugen.com OCGN|Sotuvning sof marjinal rentabelligi PACB|Benitec - Sotuvning sof rentabelligi|Sof marja Design Therapeutics DSGN|Sotuvning sof marjinal rentabelligi Rocket Pharmaceuticals RCKT|Sof foyda marjasi 4D Molecular Corp|LXEO: Sof marja|KRRO (Korro Bio, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX